Ycanth (Cantharidin) Revolutionizes Molluscum Contagiosum Treatment with FDA Approval
XTalks
AUGUST 7, 2023
Verrica, a company specializing in dermatology therapeutics, has designed Ycanth to be delivered through a single-use applicator. It then activates enzymes known as neutral serine proteases, which are responsible for protein degradation. ’s berdazimer gel, containing 10.3 Another noteworthy contender is Novan Inc.’s
Let's personalize your content